Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Inter- and intraindividual variability of riluzole serum concentrations in patients with ALS.

Journal of the neurological sciences - 15 Oct 2001

Groeneveld G J, van Kan H J, Toraño J S, Veldink J H, Guchelaar H J, Wokke J H, van den Berg L H

Abstract excerpt

All patients with amyotrophic lateral sclerosis (ALS) are treated with the same dose of riluzole: 50 mg twice daily. Reasonably large interindividual differences in clearance of the drug have been reported. The relatively small group of patients with high blood concentrations of riluzole has prob...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Age Factors
Share to Aged
Share to Amyotrophic Lateral Sclerosis

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Analysis of Variance

Share to Linear Models

Share to Neuroprotective Agents

Share to Reproducibility of Results

Share to Smoking

Source

Identifiers

PMID: 11677002
DOI: 10.1016/s0022-510x(01)00613-x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-11677002-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 8 closest

Inter- and intraindividual variability of riluzole serum concentrations in patients with ALS.PMID 11677002Read ↗

Pharmacokinetics of riluzole: evidence for glucuronidation as a major metabolic pathway not associated with UGT1A1 genotype.Semantic proximity Read ↗

Riluzole metabolism and CYP1A1/2 polymorphisms in patients with ALS.Semantic proximity Read ↗

Therapeutic drug monitoring of risperidone using a new, rapid HPLC method: reappraisal of interindividual variability factors.Semantic proximity Read ↗

Lack of efficacy of riluzole in the treatment of peripheral neuropathic pain conditionsSemantic proximity Read ↗

Serum concentrations and side effects in psychiatric patients during risperidone therapy.Semantic proximity Read ↗

Plasma concentrations and pharmacokinetics of dihydralazine after single oral doses to human subjects.Semantic proximity Read ↗

Evaluation of Clinical Outcomes of Riluzole monotherapy and Riluzole based adjunctive interventions in Amyotrophic Lateral Sclerosis: A meta-analytic and unsupervised clustering approachSemantic proximity Read ↗

Biomarkers in amyotrophic lateral sclerosis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.